Construction of a novel immune response prediction signature to predict the efficacy of immune checkpoint inhibitors in clear cell renal cell carcinoma patients

BACKGROUND: Immune checkpoint inhibitor (ICI) treatment has enhanced survival outcomes in clear cell renal cell carcinoma (ccRCC) patients. Nevertheless, the effectiveness of immunotherapy in ccRCC patients is restricted and we intended to develop and characterize an immune response prediction signa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Jiannan, Liang, Ziwei, Duan, Ling, G, Yang, Liu, Jian, An, Guangyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360603/
https://www.ncbi.nlm.nih.gov/pubmed/37484396
http://dx.doi.org/10.1016/j.heliyon.2023.e15925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360603/
https://www.ncbi.nlm.nih.gov/pubmed/37484396
http://dx.doi.org/10.1016/j.heliyon.2023.e15925

Ejemplares similares